We're transforming the future of healthcare by unlocking the power of what science can do. Intended for US HCPs. For info visit astrazeneca-us.com
Wilmington, DE
- Tweets 8,941
- Following 1,766
- Followers 80,600
- Likes 1,632
Today, we announced positive high-level results from our latest Phase III CROSSING trial in people living with eosinophilic esophagitis (EoE), a chronic epithelial-driven inflammatory disease of the esophagus. Read more about the results: bit.ly/4gBH0Eg
1
6
1,141
Last week, we welcomed the US Ambassador to the UK, Warren Stephens, to The Discovery Center, our global headquarters and state-of-the-art R&D facility in Cambridge.
1
2
1,556
The visit was a fantastic opportunity to showcase the boundary-pushing science taking place at The DISC, our role in the Cambridge and UK life sciences ecosystem and our deep commitment to the United States.
1
2
1,270
Today, the FDA has approved a new treatment option for individuals living with hypereosinophilic syndrome (HES), a rare disease driven by elevated eosinophils in the blood, which can lead to progressive organ damage over time. Read more about the approval: bit.ly/3PaNBfn
3
1,530
The FDA just announced the approval of a new way to self-administer therapy for people living with systemic lupus erythematosus (SLE). Learn more: bit.ly/4cIRzDv
1
1
4
843
Today, we begin trading on the @NYSE. This landmark moment makes it easier for investors to participate in our future and our ambitions to deliver innovative medicines to patients. spr.ly/6015hGnw5 #AZN #NYSE
3
3
12
1,833
Rick R. Suarez is appointed Senior Vice President, US President and Head of US BioPharmaceuticals. He will lead the execution of our $50B US R&D and manufacturing investment and the Company’s US BioPharmaceuticals organization. Learn more: spr.ly/6016CUYvK
2
3
1,309
#News
With @GovWesMoore, we announced plans to invest $2 billion to expand our manufacturing footprint in Maryland, part of our $50 billion investment in the US. This will support 2,600 jobs & accelerate access to innovative therapies. spr.ly/60177m7vW
5
2
3
1,028
#News We're establishing a landmark partnership with the Commonwealth of Virginia, Eli Lilly, Merck and Virginia’s higher education institutions to create the largest workforce development hub in the US for advanced pharmaceutical manufacturing: spr.ly/60177HpGt
5
1
1
1,142
Today, the FDA approved a new treatment option for chronic rhinosinusitis with nasal polyps (CRSwNP), offering patients an alternative way to help address their symptoms.
Read the full announcement: spr.ly/6014ANDdw
1
4
982
#News Today we announced our plans to invest $4.5 billion in a new manufacturing facility in Virginia. This includes a proposed $500m increase to support enhanced manufacturing capability, driving life sciences innovation and economic growth: spr.ly/6012As4Qw
7
4
8
2,521
Today, with @DaiichiSankyoUS, we announced high-level results from the TROPION-Breast02 Phase III trial of our TROP2-directed antibody drug conjugate for 1st-line metastatic triple-negative #breastcancer. Learn more about these data: bit.ly/46NnvoR #AZUS
1
2
4
1,388
The FDA has approved a supplemental new drug application for an asthma rescue medication, which now includes clinically meaningful evidence in patients with mild asthma. Discover the implications this announcement has for asthma patients. astrazeneca-us.com/media/pre…
3
1
6
894
We’re proud to share promising phase III trial results highlighting our progress toward remission-driven lupus care.
Learn more about the high-level trial results: bit.ly/46pINXQ
1
2
5
961
Today, we’ve launched a new way to access our FDA-approved influenza vaccine, helping Americans stay protected during the flu season.
Millions get the flu each year, yet vaccination rates continue to decline. Learn more: spr.ly/6011fS2hH
6
1
11
1,200
Today, in collaboration with @DaiichiSankyoUS we announced the @US_FDA approval of our treatment for adults with previously treated locally advanced or metastatic EGFR-mutated non-small cell #lungcancer #NSCLC.
Learn more: bit.ly/4kPwv12 #AZUS
3
2
8
1,460
Traditional approaches to asthma rescue may leave people with asthma at risk of exacerbations.
Learn more about our latest data, published in @NEJM: bit.ly/4koEotJ #ATS2025
2
1
4
1,743
Today, with @DaiichiSankyoUS, we announced high-level results from our DESTINY-Breast11 Phase III trial for HER2-positive early #breastcancer in the neoadjuvant setting. Learn more about the data and its potential impact for patients: spr.ly/6012NGojr #AZUS
2
2
5
1,403